skip to content

News & Articles

Full Transcript: Dr Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute, interviewed by Erin Brodwin of Business Insider

Linda Jiang

Dr. Ranjit Manchandra (left) and Erin Brodwin (right)

On this episode of Sequenced, Dr. Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute in London, sits down with Business Insider’s Erin Brodwin to discuss population-based genetic testing for cancer prevention.

Dr. Manchanda’s recent research found that population testing for multiple breast cancer genes has the potential to be both cost-effective and life-saving. Curious to learn more? The research abstract can be found here.

We’ve posted complete transcript of the podcast below. You can subscribe to Sequenced on Apple Podcasts, SoundCloud, Stitcher, and Google Play.


Breast Cancer Action Month — What Actions Can You Take to Prevent Breast Cancer?


‘Without it, we may have lost her’: A rare heart condition revealed through genetic testing

Join our mailing list.

Get Color insights straight to your inbox.